---
title: "401 Series A Healthtech Investors (Nov 2026)"
last_updated: "2026-11-09"
rows: "401"
free_rows: "25"
source: "SEC Form D filings and our own research"
canonical: "https://theinvestordatabase.com/lists/series-a-healthtech-investors/"
---

# 401 Series A healthtech investors

We list 401 Series A healthtech investors as of November 2026: 165 have an SEC filing on file and 236 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026. The states with the most are California (59), New York (18) and Florida (9).

- 401 investors
- 189 with a fund filing or dated deal in the last 12 months
- $100M median fund size on file (SEC Form D, 109 firms)
- 1,963 named decision-makers on file

## First 25 of 401 Series A healthtech investors

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| Motley Fool Ventures | VC firm | Alexandria, VA | Series A | Healthtech, Fintech, AI, Proptech | Portfolio news, Oct 2026 | $300M (SEC Form D, 2022) | 2026-11-05 | https://theinvestordatabase.com/investors/motley-fool-ventures/ |
| IW Capital | SEIS/EIS fund | London, United Kingdom | Series A | Healthtech, AI, SaaS, Fintech | New deal, Oct 2026 | £185M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/iw-capital/ |
| Felicis | VC firm | Menlo Park, CA | Seed, Series A | Healthtech, AI, Developer Tools, Cybersecurity | New deal, Oct 2026 | $900M (SEC Form D, 2025) | 2026-11-05 | https://theinvestordatabase.com/investors/felicis/ |
| Innovation Industries | VC firm | Amsterdam, Netherlands | Series A, Series B, Growth | Healthtech, Deep Tech, AI, Food and Beverage | New fund, Oct 2026 | €1.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/innovation-industries-capital-partners-b-v/ |
| Gresham House Ventures | VC firm | London, United Kingdom | Series A, Growth | Healthtech, AI, Marketing Tech, Fintech | New deal, Sep 2026 | £200M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/gresham-house-ventures/ |
| Javelin Venture Partners | VC firm | San Francisco, CA | Seed, Series A | Healthtech, AI, SaaS, Fintech | New fund, Aug 2026 | $200M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/javelin-venture-partners/ |
| Electric Capital | VC firm | Palo Alto, CA | Pre-seed, Seed, Series A | Healthtech, Crypto and Web3, AI, Fintech | New fund, Sep 2026 | $532M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/electric-capital/ |
| Salica Investments | Fund manager | London, United Kingdom | Seed, Series A, Growth | Healthtech, Fintech, AI, Climate Tech | Portfolio news, Oct 2026 | £760M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/salica/ |
| Rubio Impact Ventures | VC firm | Amsterdam, Netherlands | Seed, Series A | Healthtech, Impact, Climate Tech, Energy | New fund, Sep 2026 | €226M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/rubio-fund-management-b-v/ |
| PXN Ventures | Fund manager | Manchester, United Kingdom | Pre-seed, Seed, Series A, Growth | Healthtech, Generalist, SaaS, Deep Tech | Portfolio news, Nov 2026 | £760M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/pxn-ventures/ |
| Mercia Asset Management | Fund manager | Henley-in-Arden, United Kingdom | Seed, Series A, Growth | Healthtech, Future of Work, AI, SaaS | Portfolio news, Oct 2026 | £400M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/mercia/ |
| The FSE Group | Fund manager | Fleet, United Kingdom | Seed, Series A, Growth | Healthtech, Generalist, Climate Tech, SaaS | Portfolio news, Sep 2026 | £395M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/the-fse-group/ |
| Brightlands Venture Partners (BVP) | VC firm | Geleen, Netherlands | Seed, Series A | Healthtech, Agritech, Food and Beverage, Climate Tech | Portfolio news, Sep 2026 | €120M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/brightlands-venture-partners/ |
| Cambridge Innovation Capital | VC firm | Cambridge, United Kingdom | Seed, Series A, Growth | Healthtech, Biotech, AI, Fintech | New fund, Oct 2026 | £600M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/cambridge-innovation-capital/ |
| BGF | VC firm | United Kingdom | Seed, Series A, Series B, Growth | Healthtech, Edtech, Developer Tools, Mobility | Portfolio news, Oct 2026 | £3.0B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/bgf/ |
| ACF Investors | VC firm | Sheffield, United Kingdom | Seed, Series A | Healthtech, Fintech, Generalist, Climate Tech | Portfolio news, Oct 2026 | £100M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/acf-investors/ |
| Angelor | VC firm | Lyon, France | Seed, Series A | Healthtech, Biotech, Medtech, Food and Beverage | New deal, Sep 2026 | €100M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/angelor/ |
| M13 | VC firm | Los Angeles, CA | Seed, Series A | Healthtech, AI, Ecommerce, Consumer | New fund, Sep 2026 | $400M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/m13/ |
| P101 | VC firm | Milan, Italy | Seed, Series A, Growth | Healthtech, Generalist, SaaS, Fintech | New deal, Oct 2026 | €500M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/p101/ |
| SixThirty Ventures, LLC | VC firm | Clayton, MO | Seed, Series A | Healthtech, Fintech, AI, Insurtech | New deal, Sep 2026 | $134M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/sixthirty-ventures-llc/ |
| Cathay Innovation | VC firm | Paris, France | Seed, Series A, Series B, Growth, Late stage | Healthtech, AI, Robotics, Fintech | Portfolio news, Aug 2026 | €2.5B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/cathay-innovation/ |
| Greycroft | VC firm | New York, NY | Series A, Series B, Growth | Healthtech, AI, Industrial Tech, Defense Tech | New deal, Oct 2026 | $600M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/greycroft/ |
| Balderton Capital | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Healthtech, AI, Fintech, Developer Tools | Portfolio news, Oct 2026 | $5.7B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/balderton-capital/ |
| HBM Partners | Fund manager | Zug, Switzerland | Series A, Series B, Growth, Late stage | Healthtech, Biotech, Medtech | Portfolio news, Oct 2026 | $2.8B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hbm-partners-ag/ |
| Khosla Ventures | VC firm | Menlo Park, CA | Pre-seed, Seed, Series A, Growth | Healthtech, AI, Consumer, B2B | New fund, Aug 2026 | $1.9B (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/khosla-ventures/ |

You are seeing 25 of 401. The full list adds 376 more investors and 1,963 named decision-makers.

Get all 401 investors and 1,963 named contacts, $297, one-time: https://theinvestordatabase.com/buy/bundle
This page: https://theinvestordatabase.com/lists/series-a-healthtech-investors/

## Method and limits
- Source: 165 of the 401 rows carry an SEC filing (Form D or Form ADV). All 401 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states healthtech and digital health as a focus on its own site, or we observed it in the firm's portfolio. Stage: the firm states that it invests at Series A.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when Series A is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 401 rows: stage 401, sector 401, fund size 253, website 401. In the paid file: named decision-makers on 366 rows, firm email on 225, LinkedIn page on 292, check size on 133.

## Questions
### How many Series A healthtech investors are there?
We list 401 as of November 2026. 189 of the 401 have a fund filing or a dated deal in the last 12 months.

### Which Series A healthtech investors raised a new fund in the last 12 months?
63 of the 401 have a fund filing dated in the last 12 months. The most recent on this list are 25Madison Ventures (Oct 2026), Draper Associates (Oct 2026) and True Beauty Ventures (Oct 2026).

### What is the typical fund size of Series A healthtech investors?
The median fund size on file for this list is $100M, across the 109 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 292 do not disclose a size there.

### How do I contact Series A healthtech investors?
The paid file holds 1,963 named decision-makers across 366 of these 401 and a firm email for 225. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.

### Where does the data on Series A healthtech investors come from?
165 of the 401 rows have an SEC filing on file (Form D or Form ADV) and 236 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.